Karin Schölin Bywall

Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study?: A Disease Prevention Example in Rheumatoid Arthritis

DiSantostefano, Rachael L.; Simons, G.; Englbrecht, M.; Humphreys, Jennifer H. et al.

Ingår i Medical decision making, s. 189-202, 2024

• DOI för Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study?: A Disease Prevention Example in Rheumatoid Arthritis
• Ladda ner fulltext (pdf) av Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study?: A Disease Prevention Example in Rheumatoid Arthritis

Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment

Schölin Bywall, Karin; Esbensen, Bente Appel; Heidenvall, Marie; Erlandsson, Inger et al.

Ingår i BMC Rheumatology, 2023

• DOI för Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment
• Ladda ner fulltext (pdf) av Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment

Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment

Schölin Bywall, Karin; Drevin, Jennifer; Groothuis-Oudshoorn, Catharina; Veldwijk, Jorien et al.

Ingår i BMC Medical Ethics, 2023

• DOI för Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
• Ladda ner fulltext (pdf) av Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?: Findings and recommendations from IMI PREFER and call to action

Janssens, Rosanne; Barbier, Liese; Muller, Mireille; Cleemput, Irina et al.

Ingår i Frontiers in Pharmacology, 2023

• DOI för How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?: Findings and recommendations from IMI PREFER and call to action
• Ladda ner fulltext (pdf) av How can patient preferences be used and communicated in the regulatory evaluation of medicinal products?: Findings and recommendations from IMI PREFER and call to action

Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique

Veldwijk, Jorien; DiSantostefano, Rachael Lynn; Janssen, Ellen; Simons, Gwenda et al.

Ingår i Patient, s. 641-653, 2023

• DOI för Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
• Ladda ner fulltext (pdf) av Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique

Experiences of individuals with rheumatoid arthritis interacting with health care and the use of a digital self-care application: a qualitative interview study

Viberg Johansson, Jennifer; Blyckert, Hanna; Schölin Bywall, Karin

Ingår i BMJ Open, 2023

• DOI för Experiences of individuals with rheumatoid arthritis interacting with health care and the use of a digital self-care application: a qualitative interview study
• Ladda ner fulltext (pdf) av Experiences of individuals with rheumatoid arthritis interacting with health care and the use of a digital self-care application: a qualitative interview study

Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis

Schölin Bywall, Karin; Esbensen, Bente Appel; Lason, Marta; Heidenvall, Marie et al.

Ingår i Clinical Rheumatology, s. 695-704, 2022

• DOI för Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis
• Ladda ner fulltext (pdf) av Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania

Simons, Gwenda; Veldwijk, Jorien; Disantostefano, Rachael L.; Englbrecht, Matthias et al.

Ingår i Rheumatology, 2022

• DOI för Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
• Ladda ner fulltext (pdf) av Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania

Would you consider donating your left-over embryos to treat Parkinson’s disease? Interviews with individuals that underwent IVF in Sweden

Schölin Bywall, Karin; Holte, Jan; Brodin, Thomas; Hansson, Mats G. et al.

Ingår i BMC Medical Ethics, 2022

• DOI för Would you consider donating your left-over embryos to treat Parkinson’s disease? Interviews with individuals that underwent IVF in Sweden
• Ladda ner fulltext (pdf) av Would you consider donating your left-over embryos to treat Parkinson’s disease? Interviews with individuals that underwent IVF in Sweden

Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis

Simons, G; Schölin Bywall, Karin; Englbrecht, M; Johansson, EC et al.

Ingår i Scandinavian Journal of Rheumatology, s. 1-11, 2022

• DOI för Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis

Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis

Schölin Bywall, Karin; Viberg, Jennifer; Erlandsson, Inger; Heidenvall, Marie et al.

Ingår i BMJ Open, 2022

• DOI för Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis
• Ladda ner fulltext (pdf) av Making space for patients’ preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis

Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations

Simons, Gwenda; Caplan, Joshua; DiSantostefano, Rachael L.; Veldwijk, Jorien et al.

Ingår i Arthritis Research & Therapy, 2022

• DOI för Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
• Ladda ner fulltext (pdf) av Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations

Getting a Say: Bringing patients’ views on benefit-risk into medical approvals

Schölin Bywall, Karin

2021

• Ladda ner fulltext (pdf) av Getting a Say: Bringing patients’ views on benefit-risk into medical approvals

Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project

Falahee, Marie; Simons, Gwenda; DiSantostefano, Rachael; Valor Méndez, Larissa et al.

Ingår i BMJ Open, 2021

• DOI för Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
• Ladda ner fulltext (pdf) av Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project

Does being exposed to an educational tool influence patient preferences?: The influence of an educational tool on patient preferences assessed by a discrete choice experiment

Schölin Bywall, Karin; Veldwijk, Jorien; Hansson, Mats G.; Baecklund, Eva et al.

Ingår i Patient Education and Counseling, s. 2577-2585, 2021

• DOI för Does being exposed to an educational tool influence patient preferences?: The influence of an educational tool on patient preferences assessed by a discrete choice experiment